Phase 2a EBA Trial of AZD5847

NCT01516203 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

NIH

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: AZD5847
DRUG: Ethambutol, isoniazid, pyrazinamide, rifampin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)